AAM CEO Urges President-Elect Biden To Act On Access

As Dan Leonard Lays Out 2021 Outlook For US Generics And Biosimilars

 
• By Akriti Seth

Laying out the 2021 outlook for US generics and biosimilars, AAM president and CEO Dan Leonard has urged US president-elect Joe Biden and lawmakers in the US Congress to act to maximize savings and access to medicines.

AAM calls for bipartisan action from president-elect Biden and Congress • Source: Shutterstock

More from Biosimilars

More from Products